Read + Share
Rojo F, Conde E, Torres H, Cabezon-Gutierrez L, et al. Clinical and economic impact of 'ROS1-testing' strategy compared to a
'no-ROS1-testing' strategy in advanced NSCLC in Spain. BMC Cancer 2022;22:292.
PMID: 35303812
|
 |
|
Rojo F, Conde E, Torres H, Cabezon-Gutierrez L, et al. Clinical and economic impact of 'ROS1-testing' strategy compared to a
'no-ROS1-testing' strategy in advanced NSCLC in Spain. BMC Cancer 2022;22:292.
PMID: 35303812
|
|
|
|